AkesoBio staged a $335 million Hong Kong IPO and climbed 50% higher in its first trading session. CStone Pharma announced that China’s NMPA has accepted its NDA …
( read original story …)
The HongKong News
AkesoBio staged a $335 million Hong Kong IPO and climbed 50% higher in its first trading session. CStone Pharma announced that China’s NMPA has accepted its NDA …
( read original story …)